| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203587A1 A medicament and method for the production thereof |
| 05/08/2002 | EP1203072A2 Personal care articles |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/07/2002 | US6384259 Heat resistant, sterile dosage suitable for reconstitution with a vehicle into an injectible, particle-free product for parenteral administration |
| 05/07/2002 | US6384085 Antioxidative ingredients extracted from powdered ecklonia cava one or more times with organic solvent, fractionated one or more times in solvents, and purified by chromatography |
| 05/07/2002 | US6383528 Antithrombotic preparation to suppress neutropenia, agranulocytosis, ischemia, and other side effects from the use of ticlopidine alone; |
| 05/07/2002 | US6383522 Toxicity reduced composition containing an anti-neoplastic agent and a shark cartilage extract |
| 05/07/2002 | US6383474 Carotenoid preparation |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034262A1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 05/02/2002 | WO2002034259A1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | US20020052409 Compounds and methods for treating mitochondria-associated diseases |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | EP1201762A1 Process for producing lycopen |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200463A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
| 05/02/2002 | EP1200433A1 C-6 RING-SUBSTITUTED PYRIDO 1,2- i a /i ]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 05/02/2002 | EP1200110A1 In vivo induction for enhanced function of isolated hepatocytes |
| 05/02/2002 | EP1200095A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 05/02/2002 | EP0841907B1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/01/2002 | CN1347308A Skin care compositions contg. combination of skin care actives |
| 04/30/2002 | US6380226 For therapy of migraine, cluster headache, chronic paroxysmal hemicrania or headache associated with a vascular disorder, depression, anxiety, an eating disorder, obesity, drug abuse, hypertension and emesis |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 04/25/2002 | WO2002032447A2 Cell damage inhibitor |
| 04/25/2002 | WO2002032435A2 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade |
| 04/25/2002 | WO2002022112A9 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | CA2426381A1 Cell damage inhibitor |
| 04/24/2002 | EP1199075A2 Use of vitamine E metabolites alpha-CEHC and gamma-CEHC as antioxidants |
| 04/24/2002 | EP1199074A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/24/2002 | EP1198234A2 Bicyclic aromatic compounds for treating drug addiction |
| 04/24/2002 | EP1198229A1 Therapeutic agents |
| 04/24/2002 | EP0686149B1 Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidizing agents, method of preparation and applications in the pharmaceutical, cosmetic or food industries |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346275A Treatment of accidental extravasation of anthracyclines |
| 04/24/2002 | CN1083273C Chinese medicine detoxixation preparation of giant gold silkwork |
| 04/24/2002 | CN1083263C Use of melatonin for treating patients suffering from drug addiction |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376498 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001060378A3 Antiadhesive carbohydrates |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196172A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 04/17/2002 | EP1196169A1 Compounds having cytokine inhibitory activity |
| 04/17/2002 | EP1196167A1 Method of reducing neuronal injury or apoptosis |
| 04/17/2002 | EP1196141A1 Use of at least one extract of a plant of the genus lannea in a cosmetic or dermopharmaceutical composition |
| 04/17/2002 | EP1196136A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/17/2002 | EP1196129A1 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 04/16/2002 | US6372478 Vaccine vehicles are useful for administration to mammalian hosts for purposes of immunization |
| 04/16/2002 | US6372267 Cocoa solids prepared by heating, pressing, recovering partially defatted cocoa solids which contain cocoa polyphenols including cocoa procyanidins |
| 04/16/2002 | US6372265 Reducing curcumin in tumeric by adding calcium ion powder to the powdery curcuma (tumeric); safely enhances tumeric's antioxidant properties; edible |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028402A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | WO2002028362A2 Vaccine composition and stabilisation method |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | US20020042407 Substituted porphyrins |
| 04/11/2002 | US20020041905 Solvent extraction of plant extracts; activation; antituor agents |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2424863A1 Vaccine composition and stabilisation method |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424607A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP0946516B1 New histidine derivatives, preparation process, and their use as free antiradical agents |
| 04/10/2002 | CN1344262A Perfuoroalkylamide, prodn. thereof and use thereof in diagnostics |
| 04/10/2002 | CN1343493A Application of N-gluco-N-bithiocarboxylic acid-L-amino acid sodium in repelling Pt |
| 04/10/2002 | CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor |
| 04/04/2002 | WO2001085142A8 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 04/04/2002 | WO2001032219A3 Treatment of c. difficile toxin b associated conditions |
| 04/04/2002 | US20020040053 Administering 2,5,7,8-tetramethyl-2-( beta-carboxyethyl)-6-hydroxychromane, or 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychromane; treating arteriosclerosis, disease caused by oxidated low density lipoprotein |
| 04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 04/03/2002 | EP1191948A2 High dose radionuclide complexes for bone marrow suppression |
| 04/03/2002 | CN1342463A Health-care propolis-chitosan medicine |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |